$AHR
American Healthcare REIT, Inc. Stock $ahr

$ahr Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000163297018000117 Filed on August 10, 2018

Income Statement

Concept	2018 Q2	2017 Q2
Revenue	$19.01M	$6.198M
YoY Change	206.71%	206500.0%
Cost Of Revenue	$2.552M
YoY Change
Gross Profit	$16.46M
YoY Change
Gross Profit Margin	86.58%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.781M	$1.665M
YoY Change	127.09%
% of Gross Profit	22.97%
Operating Expenses
YoY Change
Operating Profit		$1.029M
YoY Change		-267.86%
Interest Expense	$1.160M	$409.0K
YoY Change	183.62%
% of Operating Profit		39.75%
Other Income/Expense, Net	$1.160M	$408.0K
YoY Change	184.31%
Pretax Income	-$958.0K
YoY Change
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$900.0K	$621.0K
YoY Change	-244.93%	-201.31%
Net Earnings / Revenue	-4.73%	10.02%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q2	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$26.79M	$3.247M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$45.70M	$36.11M
YoY Change	26.55%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$573.4M	$349.5M
YoY Change	64.08%	2178.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$126.0M	$107.4M
YoY Change	17.31%	3035.97%
SHAREHOLDERS EQUITY
Retained Earnings	-$40.92M	-$12.59M
YoY Change	225.13%	1378.85%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity	$573.4M	$349.5M
YoY Change	64.08%	2178.19%

Cashflow Statement

Concept	2018 Q2	2017 Q2
OPERATING ACTIVITIES
Net Income	-$900.0K	$621.0K
YoY Change	-244.93%	-201.31%
Depreciation, Depletion And Amortization	$3.781M	$1.665M
YoY Change	127.09%
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
	dei	Document Period End Date DocumentPeriodEndDate	2018-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001632970
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2015-01-23
	dei	Entity Registrant Name EntityRegistrantName	Griffin-American Healthcare REIT IV, Inc.
	dei	Trading Symbol TradingSymbol	gahr4
CY2017Q2	gahr	Accrued Contingent Advisor Payment AccruedContingentAdvisorPayment	7774000	USD
CY2018Q2	gahr	Accrued Contingent Advisor Payment AccruedContingentAdvisorPayment	7790000	USD
CY2017Q2	gahr	Accruedstockholderservicingfee Accruedstockholderservicingfee	9603000	USD
CY2018Q2	gahr	Accruedstockholderservicingfee Accruedstockholderservicingfee	14351000	USD
CY2017Q4	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	9000	USD
CY2018Q2	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	21000	USD
	gahr	Acquisition Aggregated Cost Of Acquired Properties Purchase Price AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePrice	536090000	USD
	gahr	Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests	0	USD
	gahr	Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests	125000	USD
CY2017	gahr	Advisory Agreement Term AdvisoryAgreementTerm	P1Y
CY2016Q1	gahr	Aggregate Maximum Amount Of Common Stock Issuable Under Public Offering AggregateMaximumAmountOfCommonStockIssuableUnderPublicOffering	3150000000	USD
CY2016Q2	gahr	Aggregate Reallocated Maximum Amountof Common Stock Issuable Under Primary Public Offering AggregateReallocatedMaximumAmountofCommonStockIssuableUnderPrimaryPublicOffering	3150000000	USD
CY2017Q2	gahr	Amortization Expense On Lease Commissions AmortizationExpenseOnLeaseCommissions	0	USD
	gahr	Amortization Expense On Lease Commissions AmortizationExpenseOnLeaseCommissions	0	USD
CY2018Q2	gahr	Amortization Expense On Lease Commissions AmortizationExpenseOnLeaseCommissions	10000	USD
	gahr	Amortization Expense On Lease Commissions AmortizationExpenseOnLeaseCommissions	18000	USD
CY2017Q2	gahr	Amortizationof Identified Intangible Liabilities AmortizationofIdentifiedIntangibleLiabilities	69000	USD
	gahr	Amortizationof Identified Intangible Liabilities AmortizationofIdentifiedIntangibleLiabilities	137000	USD
CY2018Q2	gahr	Amortizationof Identified Intangible Liabilities AmortizationofIdentifiedIntangibleLiabilities	122000	USD
	gahr	Amortizationof Identified Intangible Liabilities AmortizationofIdentifiedIntangibleLiabilities	207000	USD
	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	8000	USD
	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	33000	USD
CY2018Q2	gahr	Ancillaryservicerevenue Ancillaryservicerevenue	234000	USD
	gahr	Ancillaryservicerevenue Ancillaryservicerevenue	420000	USD
	gahr	Borrowingsandassumptionsonmortgageloanspayablenet Borrowingsandassumptionsonmortgageloanspayablenet	8000000	USD
	gahr	Borrowingsandassumptionsonmortgageloanspayablenet Borrowingsandassumptionsonmortgageloanspayablenet	5808000	USD
	gahr	Capitalized Acquisition Costsand Fees Additions CapitalizedAcquisitionCostsandFeesAdditions	2073000	USD
	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	151000	USD
	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	123000	USD
	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	77746	shares
	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	198129	shares
CY2017Q2	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	7174	shares
	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	7174	shares
CY2018Q2	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	79195	shares
	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	120383	shares
	gahr	Condition Two Percentage Of Operating Expense Of Net Income ConditionTwoPercentageOfOperatingExpenseOfNetIncome	0.250
CY2017Q2	gahr	Dealer Manager Fees DealerManagerFees	889000	USD
	gahr	Dealer Manager Fees DealerManagerFees	1622000	USD
CY2018Q2	gahr	Dealer Manager Fees DealerManagerFees	568000	USD
	gahr	Dealer Manager Fees DealerManagerFees	1061000	USD
CY2018Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses After Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive	678000	USD
CY2018Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear	173000	USD
CY2018Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive	120000	USD
CY2018Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Four FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour	129000	USD
CY2018Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Three FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree	154000	USD
CY2018Q2	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Two FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo	318000	USD
CY2017	gahr	Finite Lived Intangible Liabilities Useful Life FiniteLivedIntangibleLiabilitiesUsefulLife	P16Y8M12D
	gahr	Finite Lived Intangible Liabilities Useful Life FiniteLivedIntangibleLiabilitiesUsefulLife	P17Y3M18D
CY2016Q3	gahr	Line Of Credit Facility Number Of Potential Extensions LineOfCreditFacilityNumberOfPotentialExtensions	1	Extension
CY2017Q4	gahr	Line Of Credit Facility Number Of Potential Extensions LineOfCreditFacilityNumberOfPotentialExtensions	1	Extension_period
CY2016Q3	gahr	Line Of Credit Facility Potential Extension Term LineOfCreditFacilityPotentialExtensionTerm	P12M
CY2017Q4	gahr	Line Of Credit Facility Potential Extension Term LineOfCreditFacilityPotentialExtensionTerm	P12M
CY2017Q4	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	82644000	USD
CY2018Q2	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	73368000	USD
CY2017Q4	gahr	Maximum Investment Rate By Officer Evp MaximumInvestmentRateByOfficerEVP	0.15
CY2016Q4	gahr	Maximum Investment Rate By Officer Evp MaximumInvestmentRateByOfficerEVP	0.150
	gahr	Maximum Percentage Of Common Stock Repurchased During Period MaximumPercentageOfCommonStockRepurchasedDuringPeriod	0.050
	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.060
	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.060
	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.060
	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.06
	gahr	Maximumpercentageofdealermanagerfee Maximumpercentageofdealermanagerfee	0.030
	gahr	Maximumpercentageofdealermanagerfee Maximumpercentageofdealermanagerfee	0.030
CY2017	gahr	Maximumpercentageofstockholderservicingfee Maximumpercentageofstockholderservicingfee	0.040
CY2017Q4	gahr	Minimum Investment Rate By Officer Evp MinimumInvestmentRateByOfficerEVP	0.05
CY2016Q4	gahr	Minimum Investment Rate By Officer Evp MinimumInvestmentRateByOfficerEVP	0.050
CY2018Q2	gahr	Minimum Percent Share Of Annualized Base Rent Accounted By Tenants MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants	0.100
CY2018Q2	gahr	Minimum Percent Share Of Each State Annualized Base Rent That Company Owned MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned	0.1
	gahr	Number Of Buildings Acquired From Unaffiliated Parties NumberOfBuildingsAcquiredFromUnaffiliatedParties	45	Building
CY2017Q4	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	2	MortgageLoan
CY2018Q2	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	3	MortgageLoan
CY2018Q2	gahr	Number Of Tenants With More Than Ten Percent Of Annual Base Rent NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent	1
	gahr	Numberof Acquisitions Completedfrom Unaffiliated Parties NumberofAcquisitionsCompletedfromUnaffiliatedParties	22	Acquisition
	gahr	Numberof Properties Acquiredfrom Unaffiliated Parties NumberofPropertiesAcquiredfromUnaffiliatedParties	43	Property
	gahr	Other Amortization OtherAmortization	157000	USD
	gahr	Other Amortization OtherAmortization	389000	USD
	gahr	Ownership Percentage Properties OwnershipPercentageProperties	1.00
	gahr	Payments For Proceeds From Security Deposits Financing Activities PaymentsForProceedsFromSecurityDepositsFinancingActivities	0	USD
	gahr	Payments For Proceeds From Security Deposits Financing Activities PaymentsForProceedsFromSecurityDepositsFinancingActivities	-16000	USD
	gahr	Paymentsfor Preacquisitionexpenses PaymentsforPreacquisitionexpenses	0	USD
	gahr	Paymentsfor Preacquisitionexpenses PaymentsforPreacquisitionexpenses	137000	USD
	gahr	Percentage Of Dealer Manager Fee PercentageOfDealerManagerFee	0.010
	gahr	Percentage Of Dealer Manager Fee PercentageOfDealerManagerFee	0.010
	gahr	Preacquisitionexpenses Incurredbut Notyet Paid PreacquisitionexpensesIncurredbutNotyetPaid	0	USD
	gahr	Preacquisitionexpenses Incurredbut Notyet Paid PreacquisitionexpensesIncurredbutNotyetPaid	402000	USD
CY2017Q2	gahr	Receivable From Transfer Agent ReceivableFromTransferAgent	906000	USD
CY2018Q2	gahr	Receivable From Transfer Agent ReceivableFromTransferAgent	957000	USD
CY2017Q2	gahr	Selling Commissions Expenses SellingCommissionsExpenses	2634000	USD
	gahr	Selling Commissions Expenses SellingCommissionsExpenses	4704000	USD
CY2018Q2	gahr	Selling Commissions Expenses SellingCommissionsExpenses	1679000	USD
	gahr	Selling Commissions Expenses SellingCommissionsExpenses	3141000	USD
	gahr	Selling Commissions Percentage SellingCommissionsPercentage	0.030
	gahr	Share Repurchase Plan Holding Period Condition One ShareRepurchasePlanHoldingPeriodConditionOne	P1Y
CY2018Q2	gahr	Share Repurchase Plan Percentageof Priceper Share Condition One ShareRepurchasePlanPercentageofPriceperShareConditionOne	0.925
CY2018Q2	gahr	Share Repurchase Plan Percentageof Priceper Share Condition Two ShareRepurchasePlanPercentageofPriceperShareConditionTwo	1.00
	gahr	Sharesissuedindiscount Sharesissuedindiscount	3000	USD
	gahr	Sharesissuedindiscount Sharesissuedindiscount	0	USD
	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.45
	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.42
CY2017Q2	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.66
	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.66
CY2018Q2	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.28
	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.40
	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	735000	USD
	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	1867000	USD
CY2017Q2	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	69000	USD
	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	69000	USD
CY2018Q2	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	735000	USD
	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	1132000	USD
CY2017Q2	gahr	Stockholder Servicing Fee Incurred StockholderServicingFeeIncurred	3384000	USD
	gahr	Stockholder Servicing Fee Incurred StockholderServicingFeeIncurred	6138000	USD
CY2018Q2	gahr	Stockholder Servicing Fee Incurred StockholderServicingFeeIncurred	1918000	USD
	gahr	Stockholder Servicing Fee Incurred StockholderServicingFeeIncurred	3618000	USD
CY2017Q4	gahr	Stockholder Servicing Fee Payable StockholderServicingFeePayable	12611000	USD
CY2018Q2	gahr	Stockholder Servicing Fee Payable StockholderServicingFeePayable	14351000	USD
	gahr	Stockholderdailyservicingfeepercentage Stockholderdailyservicingfeepercentage	0.010
	gahr	Tenant Improvement Overage TenantImprovementOverage	0	USD
	gahr	Tenant Improvement Overage TenantImprovementOverage	435000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	19428000	USD
CY2018Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	22963000	USD
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2838000	USD
CY2018Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	5921000	USD
CY2017Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	554000	USD
CY2018Q2	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	991000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	376284000	USD
CY2018Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	486789000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2017Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	90000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	177000	USD
CY2018Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	219000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	437000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	859000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1487000	USD
CY2018Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4124000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7957000	USD
CY2018Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	2727000	sqft
CY2017Q2	us-gaap	Asset Management Fees1 AssetManagementFees1	504000	USD
	us-gaap	Asset Management Fees1 AssetManagementFees1	805000	USD
CY2018Q2	us-gaap	Asset Management Fees1 AssetManagementFees1	1070000	USD
	us-gaap	Asset Management Fees1 AssetManagementFees1	2028000	USD
CY2017Q4	us-gaap	Assets Assets	480153000	USD
CY2018Q2	us-gaap	Assets Assets	573416000	USD
CY2017Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	140000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	213000	USD
CY2018Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	61000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	156000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	719000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	697000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2237000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3247000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7087000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7087000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26788000	USD
CY2018Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26788000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2237000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3263000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7103000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	26950000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1026000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	19847000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2018Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.15
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2017Q2	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	1611000	USD
	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	2798000	USD
CY2018Q2	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	2552000	USD
	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	4903000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	5169000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	8888000	USD
CY2018Q2	us-gaap	Costs And Expenses CostsAndExpenses	18808000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	37802000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11634000	USD
CY2018Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	17505000	USD
CY2018Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	17505000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	11000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	10000	USD
CY2017Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	326000	USD
CY2018Q2	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	546000	USD
CY2018Q2	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-642000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1382000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1456000	USD
CY2018Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1032000	USD
CY2017Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	1912000	USD
CY2018Q2	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	3248000	USD
CY2018Q2	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-133000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-286000	USD
CY2017Q2	us-gaap	Depreciation Depreciation	1665000	USD
	us-gaap	Depreciation Depreciation	2805000	USD
CY2018Q2	us-gaap	Depreciation Depreciation	3781000	USD
	us-gaap	Depreciation Depreciation	7197000	USD
CY2017Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2466000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4177000	USD
CY2018Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7851000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15046000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4177000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	15046000	USD
CY2017Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1351000	USD
CY2018Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2641000	USD
CY2017Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	8118000	USD
CY2018Q2	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	8225000	USD
CY2017Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8118000	USD
CY2018Q2	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8225000	USD
CY2017Q4	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	500000	USD
CY2018Q2	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	9065000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2017	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P16Y2M12D
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P16Y7M6D
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	20077000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	6577000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	3583000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4433000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4985000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6047000	USD
CY2018Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	45702000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	952000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1700000	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1578000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3698000	USD
CY2017Q2	us-gaap	Health Care Organization Resident Service Revenue HealthCareOrganizationResidentServiceRevenue	0	USD
	us-gaap	Health Care Organization Resident Service Revenue HealthCareOrganizationResidentServiceRevenue	0	USD
CY2018Q2	us-gaap	Health Care Organization Resident Service Revenue HealthCareOrganizationResidentServiceRevenue	8426000	USD
	us-gaap	Health Care Organization Resident Service Revenue HealthCareOrganizationResidentServiceRevenue	16835000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	7000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	6000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	103000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	2743000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	963000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1388000	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	123000	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	55000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-109000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-11000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	326000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	122000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	44821000	USD
CY2018Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45702000	USD
CY2017Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	1000	USD
	us-gaap	Interest Expense InterestExpense	2244000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	1000	USD
CY2018Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	409000	USD
	us-gaap	Interest Expense InterestExpense	827000	USD
CY2018Q2	us-gaap	Interest Expense InterestExpense	1160000	USD
	us-gaap	Interest Paid InterestPaid	672000	USD
	us-gaap	Interest Paid InterestPaid	1796000	USD
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	1000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	125927000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	125999000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	480153000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	573416000	USD
CY2017	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest	0.9999
	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest	0.9999
CY2017	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Members Or Limited Partners Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest	0.0001
	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Members Or Limited Partners Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest	0.0001
CY2017Q4	us-gaap	Line Of Credit LineOfCredit	84100000	USD
CY2017Q4	us-gaap	Line Of Credit LineOfCredit	84100000	USD
CY2018Q2	us-gaap	Line Of Credit LineOfCredit	74400000	USD
CY2018Q2	us-gaap	Line Of Credit LineOfCredit	74400000	USD
CY2016Q3	us-gaap	Line Of Credit Facility Collateral LineOfCreditFacilityCollateral	750000000
CY2017Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	84088000	USD
CY2018Q2	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	74388000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	200000000	USD
CY2018Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	200000000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	200000000	USD
CY2017Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	11819000	USD
CY2018Q2	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	17070000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	7698000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	455000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	434000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	8151000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	519000	USD
CY2018Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	248000	USD
CY2017Q4	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.0001
CY2018Q2	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.0001
CY2017Q4	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.9999
CY2018Q2	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.9999
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	195071000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	88090000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-199018000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-77936000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4973000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9693000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	5808000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	621000	USD
	us-gaap	Net Income Loss NetIncomeLoss	536000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-900000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-3069000	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	USD
CY2018Q2	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-58000	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-125000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	8000000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	122000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	83000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	519000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	371000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	743000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	230000	USD
CY2018Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2018Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	3	State
CY2017Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1737000	USD
CY2017Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1737000	USD
CY2018Q2	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1572000	USD
CY2018Q2	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1572000	USD
CY2017Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	6198000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	10250000	USD
CY2018Q2	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	10584000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	20017000	USD
	us-gaap	Operations Commenced Date1 OperationsCommencedDate1	2015-02-06
CY2017Q4	us-gaap	Other Assets OtherAssets	5226000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	5226000	USD
CY2018Q2	us-gaap	Other Assets OtherAssets	6728000	USD
CY2018Q2	us-gaap	Other Assets OtherAssets	6728000	USD
CY2017Q4	us-gaap	Other Liabilities OtherLiabilities	977000	USD
CY2018Q2	us-gaap	Other Liabilities OtherLiabilities	1754000	USD
CY2017Q2	us-gaap	Owned Property Management Costs OwnedPropertyManagementCosts	0	USD
	us-gaap	Owned Property Management Costs OwnedPropertyManagementCosts	0	USD
CY2018Q2	us-gaap	Owned Property Management Costs OwnedPropertyManagementCosts	6766000	USD
	us-gaap	Owned Property Management Costs OwnedPropertyManagementCosts	13999000	USD
CY2017Q2	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	2000	USD
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	3000	USD
CY2018Q2	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	4000	USD
	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	8000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	33000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	3729000	USD
	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	-179000	USD
	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	8565000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	69000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	9118000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	164000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	129000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	8697000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1132000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2077000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6076000	USD
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	199164000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	65505000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1532000	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1902000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	169003000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	114461000	USD
	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	9485000	USD
	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	17252000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	172100000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	116500000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	621000	USD
	us-gaap	Profit Loss ProfitLoss	536000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	-958000	USD
	us-gaap	Profit Loss ProfitLoss	-3194000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	69000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	146000	USD
CY2017Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	8885000	USD
CY2018Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	15945000	USD
CY2017Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	428550000	USD
CY2018Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	494995000	USD
CY2017Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	419665000	USD
CY2017Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	419665000	USD
CY2018Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	479050000	USD
CY2018Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	479050000	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	2000	USD
CY2017Q2	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	2000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	1002000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	1002000	USD
CY2018Q2	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	1002000	USD
CY2018Q2	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	1002000	USD
CY2017Q2	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	5688000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	9777000	USD
CY2018Q2	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	4154000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	7129000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	125000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	134900000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	126200000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	125000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	200000	USD
CY2016Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2017Q2	us-gaap	Restricted Cash RestrictedCash	16000	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	16000	USD
CY2018Q2	us-gaap	Restricted Cash RestrictedCash	162000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16000	USD
CY2018Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	162000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23482000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-40918000	USD
CY2017Q2	us-gaap	Revenues Revenues	4587000	USD
	us-gaap	Revenues Revenues	7452000	USD
CY2018Q2	us-gaap	Revenues Revenues	9692000	USD
	us-gaap	Revenues Revenues	17950000	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	6198000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	10250000	USD
CY2018Q2	us-gaap	Sales Revenue Net SalesRevenueNet	19010000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	36852000	USD
CY2016Q4	us-gaap	Secured Debt SecuredDebt	3965000	USD
CY2017Q2	us-gaap	Secured Debt SecuredDebt	11691000	USD
CY2017Q4	us-gaap	Secured Debt SecuredDebt	11567000	USD
CY2018Q2	us-gaap	Secured Debt SecuredDebt	17085000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	39000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	75000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	45000	shares
	us-gaap	Stock Issued1 StockIssued1	2874000	USD
	us-gaap	Stock Issued1 StockIssued1	7767000	USD
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	1008075	shares
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	1826609	shares
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	1826609	shares
CY2017Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1811000	USD
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	2874000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	4161000	USD
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	7767000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	353224000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	446415000	USD
	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-556000	USD
	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-1336000	USD
CY2018Q2	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	775000	USD
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1668000	USD
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24035973	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	19371454	shares
CY2018Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	51277753	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	48224165	shares
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1. Organization and Description of Business</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:10px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Griffin-American Healthcare REIT IV, Inc., a Maryland corporation, was incorporated on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January 23, 2015</font><font style="font-family:inherit;font-size:10pt;"> and therefore we consider that our date of inception. We were initially capitalized on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">February 6, 2015</font><font style="font-family:inherit;font-size:10pt;">. We invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings, hospitals, skilled nursing facilities, senior housing and other healthcare-related facilities. We also operate healthcare-related facilities utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure (the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted as part of the Housing and Economic Recovery Act of 2008). We may also originate and acquire secured loans and real estate-related investments on an infrequent and opportunistic basis. We generally seek investments that produce current income. We qualified to be taxed as a real estate investment trust, or REIT, under the Code for federal income tax purposes beginning with our taxable year ended December 31, 2016, and we intend to continue to qualify to be taxed as a REIT.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 16, 2016, we commenced our initial public offering, or our offering, in which we were initially offering to the public up to </font><font style="font-family:inherit;font-size:10pt;">$3,150,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock, consisting of up to </font><font style="font-family:inherit;font-size:10pt;">$3,000,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock at a price of </font><font style="font-family:inherit;font-size:10pt;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share in our primary offering and up to </font><font style="font-family:inherit;font-size:10pt;">$150,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock for </font><font style="font-family:inherit;font-size:10pt;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share pursuant to our distribution reinvestment plan, as amended, or the DRIP. Effective June 17, 2016, we reallocated certain of the unsold shares of Class T common stock being offered and began offering shares of Class I common stock, such that we are currently offering up to approximately </font><font style="font-family:inherit;font-size:10pt;">$2,800,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of Class T common stock and </font><font style="font-family:inherit;font-size:10pt;">$200,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of Class I common stock in our primary offering, and up to an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$150,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T and Class I common stock pursuant to the DRIP, aggregating up to </font><font style="font-family:inherit;font-size:10pt;">$3,150,000,000</font><font style="font-family:inherit;font-size:10pt;"> or the maximum offering amount. </font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The shares of our Class T common stock in our primary offering were being offered at a price of </font><font style="font-family:inherit;font-size:10pt;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share prior to April 11, 2018. The shares of our Class I common stock in our primary offering were being offered at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.30</font><font style="font-family:inherit;font-size:10pt;"> per share prior to March 1, 2017 and </font><font style="font-family:inherit;font-size:10pt;">$9.21</font><font style="font-family:inherit;font-size:10pt;"> per share from March 1, 2017 to April 10, 2018. The shares of our Class T and Class I common stock issued pursuant to the DRIP were sold at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share prior to January 1, 2017 and </font><font style="font-family:inherit;font-size:10pt;">$9.40</font><font style="font-family:inherit;font-size:10pt;"> per share from January 1, 2017 to April 10, 2018. On April 6, 2018, our board of directors, at the recommendation of the audit committee of our board of directors, comprised solely of independent directors, unanimously approved and established an estimated per share net asset value, or NAV, of our common stock of </font><font style="font-family:inherit;font-size:10pt;">$9.65</font><font style="font-family:inherit;font-size:10pt;">. As a result, on April 6, 2018, our board of directors unanimously approved revised offering prices for each class of shares of our common stock to be sold in the primary portion of our initial public offering based on the estimated per share NAV of our Class T and Class I common stock of </font><font style="font-family:inherit;font-size:10pt;">$9.65</font><font style="font-family:inherit;font-size:10pt;"> plus any applicable per share up-front selling commissions and dealer manager fees funded by us, effective April 11, 2018. Accordingly, the revised offering price for shares of our Class T common stock and Class I common stock sold pursuant to our primary offering on or after April 11, 2018 is </font><font style="font-family:inherit;font-size:10pt;">$10.05</font><font style="font-family:inherit;font-size:10pt;"> per share and </font><font style="font-family:inherit;font-size:10pt;">$9.65</font><font style="font-family:inherit;font-size:10pt;"> per share, respectively. Effective April 11, 2018, the shares of our Class T and Class I common stock issued pursuant to the DRIP are sold at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.65</font><font style="font-family:inherit;font-size:10pt;"> per share, the most recent estimated per share NAV approved and established by our board of directors.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We will sell shares of our Class T and Class I common stock in our offering until the earlier of February 16, 2019 or the date on which the maximum offering amount has been sold. We reserve the right to reallocate the shares of common stock we are offering between the primary offering and the DRIP, and among classes of stock. As of </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, we had received and accepted subscriptions in our offering for </font><font style="font-family:inherit;font-size:10pt;">52,749,116</font><font style="font-family:inherit;font-size:10pt;"> aggregate shares of our Class T and Class I common stock, or approximately </font><font style="font-family:inherit;font-size:10pt;">$525,121,000</font><font style="font-family:inherit;font-size:10pt;">, excluding shares of our common stock issued pursuant to the DRIP.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We conduct substantially all of our operations through Griffin-American Healthcare REIT IV Holdings, LP, or our operating partnership. We are externally advised by Griffin-American Healthcare REIT IV Advisor, LLC, or our advisor, pursuant to an advisory agreement, or the Advisory Agreement, between us and our advisor. The Advisory Agreement was effective as of February 16, 2016 and had a </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">-year term, subject to successive </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">-year renewals upon the mutual consent of the parties. The Advisory Agreement was last renewed pursuant to the mutual consent of the parties on February 14, 2018 and expires on February 16, 2019. Our advisor uses its best efforts, subject to the oversight and review of our board of directors, to, among other things, research, identify, review and make investments in and dispositions of properties and securities on our behalf consistent with our investment policies and objectives. Our advisor performs its duties and responsibilities under the Advisory Agreement as our fiduciary. Our advisor is </font><font style="font-family:inherit;font-size:10pt;">75.0%</font><font style="font-family:inherit;font-size:10pt;"> owned and managed by American Healthcare Investors, LLC, or American Healthcare Investors, and </font><font style="font-family:inherit;font-size:10pt;">25.0%</font><font style="font-family:inherit;font-size:10pt;"> owned by a wholly owned subsidiary of Griffin Capital Company, LLC, or Griffin Capital, or collectively, our co-sponsors. American Healthcare Investors is </font><font style="font-family:inherit;font-size:10pt;">47.1%</font><font style="font-family:inherit;font-size:10pt;"> owned by AHI Group Holdings, LLC, or AHI Group Holdings, </font><font style="font-family:inherit;font-size:10pt;">45.1%</font><font style="font-family:inherit;font-size:10pt;"> indirectly owned by Colony Capital, Inc. (NYSE: CLNY), or Colony Capital, and </font><font style="font-family:inherit;font-size:10pt;">7.8%</font><font style="font-family:inherit;font-size:10pt;"> owned by James F. Flaherty III, a former partner of Colony Capital. We are not affiliated with Griffin Capital, Griffin Capital Securities, LLC, or our dealer manager, Colony Capital or Mr. Flaherty; however, we are affiliated with Griffin-American Healthcare REIT IV Advisor, LLC, American Healthcare Investors and AHI Group Holdings.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We currently operate through </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> reportable business segments — medical office buildings, senior housing, senior housing — RIDEA and skilled nursing facilities. As of </font><font style="font-family:inherit;font-size:10pt;">June 30, 2018</font><font style="font-family:inherit;font-size:10pt;">, we had completed </font><font style="font-family:inherit;font-size:10pt;">22</font><font style="font-family:inherit;font-size:10pt;"> property acquisitions whereby we owned </font><font style="font-family:inherit;font-size:10pt;">43</font><font style="font-family:inherit;font-size:10pt;"> properties, comprising </font><font style="font-family:inherit;font-size:10pt;">45</font><font style="font-family:inherit;font-size:10pt;"> buildings, or approximately </font><font style="font-family:inherit;font-size:10pt;">2,727,000</font><font style="font-family:inherit;font-size:10pt;"> square feet of gross leasable area, or GLA, for an aggregate contract purchase price of </font><font style="font-family:inherit;font-size:10pt;">$536,090,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:10px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of our accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are made and evaluated on an on-going basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0001632970-18-000117-index-headers.html	Edgar Link	pending
0001632970-18-000117-index.html	Edgar Link	pending
0001632970-18-000117.txt	Edgar Link	pending
0001632970-18-000117-xbrl.zip	Edgar Link	pending
ex101missourisnfpsa.htm	Edgar Link	pending
ex311-gahr4x10xq2018xq2.htm	Edgar Link	pending
ex312-gahr4x10xq2018xq2.htm	Edgar Link	pending
ex321-gahr4x10xq2018xq2.htm	Edgar Link	pending
ex322-gahr4x10xq2018xq2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gahr-20180630.xml	Edgar Link	completed
gahr-20180630.xsd	Edgar Link	pending
gahr-20180630_cal.xml	Edgar Link	unprocessable
gahr-20180630_def.xml	Edgar Link	unprocessable
gahr-20180630_lab.xml	Edgar Link	unprocessable
gahr-20180630_pre.xml	Edgar Link	unprocessable
gahr4-10xq2018xq2.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHR
American Healthcare REIT, Inc. Stock $ahr

2018 Q2 Form 10-Q Financial Statement

#000163297018000117 Filed on August 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR American Healthcare REIT, Inc. Stock $ahr

2018 Q2 Form 10-Q Financial Statement

#000163297018000117 Filed on August 10, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR
American Healthcare REIT, Inc. Stock $ahr